-
Je něco špatně v tomto záznamu ?
The specific PKC-α inhibitor chelerythrine blunts costunolide-induced eryptosis
M. Ghashghaeinia, P. Koralkova, D. Giustarini, R. Mojzikova, B. Fehrenbacher, P. Dreischer, M. Schaller, U. Mrowietz, A. Martínez-Ruiz, T. Wieder, V. Divoky, R. Rossi, F. Lang, M. Köberle
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
ProQuest Central
od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2000-02-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-01-01 do Před 1 rokem
- MeSH
- apoptóza účinky léků MeSH
- benzofenantridiny farmakologie MeSH
- eryptóza účinky léků genetika MeSH
- erytrocyty účinky léků patologie MeSH
- glukosa-6-fosfátdehydrogenasa antagonisté a inhibitory genetika MeSH
- glutathion genetika MeSH
- inhibitory enzymů farmakologie MeSH
- lidé MeSH
- oxidační stres účinky léků MeSH
- proteinkinasa C-alfa antagonisté a inhibitory genetika MeSH
- reaktivní formy kyslíku MeSH
- seskviterpeny farmakologie MeSH
- vápník metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Costunolide, a natural sesquiterpene lactone, has multiple pharmacological activities such as neuroprotection or induction of apoptosis and eryptosis. However, the effects of costunolide on pro-survival factors and enzymes in human erythrocytes, e.g. glutathione and glucose-6-phosphate dehydrogenase (G6PDH) respectively, have not been studied yet. Our aim was to determine the mechanisms underlying costunolide-induced eryptosis and to reverse this process. Phosphatidylserine exposure was estimated from annexin-V-binding, cell volume from forward scatter in flow cytometry, and intracellular glutathione [GSH]i from high performance liquid chromatography. The oxidized status of intracellular glutathione and enzyme activities were measured by spectrophotometry. Treatment of erythrocytes with costunolide dose-dependently enhanced the percentage of annexin-V-binding cells, decreased the cell volume, depleted [GSH]i and completely inhibited G6PDH activity. The effects of costunolide on annexin-V-binding and cell volume were significantly reversed by pre-treatment of erythrocytes with the specific PKC-α inhibitor chelerythrine. The latter, however, had no effect on costunolide-induced GSH depletion. Costunolide induces eryptosis, depletes [GSH]i and inactivates G6PDH activity. Furthermore, our study reveals an inhibitory effect of chelerythrine on costunolide-induced eryptosis, indicating a relationship between costunolide and PKC-α. In addition, chelerythrine acts independently of the GSH depletion. Understanding the mechanisms of G6PDH inhibition accompanied by GSH depletion should be useful for development of anti-malarial therapeutic strategies or for synthetic lethality-based approaches to escalate oxidative stress in cancer cells for their sensitization to chemotherapy and radiotherapy.
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares Madrid Spain
Department of Dermatology Eberhard Karls University of Tübingen 72074 Tübingen Germany
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21026498
- 003
- CZ-PrNML
- 005
- 20211026132842.0
- 007
- ta
- 008
- 211013s2020 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s10495-020-01620-6 $2 doi
- 035 __
- $a (PubMed)32638182
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Ghashghaeinia, Mehrdad $u Psoriasis-Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Rosalind-Franklin-Str. 7, 24105, Kiel, Germany. mghashghaeinia@dermatology.uni-kiel.de $u Physiologisches Institut, Abteilung für Vegetative Und Klinische Physiologie, Eberhard Karls University of Tübingen, 72074, Tübingen, Germany. mghashghaeinia@dermatology.uni-kiel.de
- 245 14
- $a The specific PKC-α inhibitor chelerythrine blunts costunolide-induced eryptosis / $c M. Ghashghaeinia, P. Koralkova, D. Giustarini, R. Mojzikova, B. Fehrenbacher, P. Dreischer, M. Schaller, U. Mrowietz, A. Martínez-Ruiz, T. Wieder, V. Divoky, R. Rossi, F. Lang, M. Köberle
- 520 9_
- $a Costunolide, a natural sesquiterpene lactone, has multiple pharmacological activities such as neuroprotection or induction of apoptosis and eryptosis. However, the effects of costunolide on pro-survival factors and enzymes in human erythrocytes, e.g. glutathione and glucose-6-phosphate dehydrogenase (G6PDH) respectively, have not been studied yet. Our aim was to determine the mechanisms underlying costunolide-induced eryptosis and to reverse this process. Phosphatidylserine exposure was estimated from annexin-V-binding, cell volume from forward scatter in flow cytometry, and intracellular glutathione [GSH]i from high performance liquid chromatography. The oxidized status of intracellular glutathione and enzyme activities were measured by spectrophotometry. Treatment of erythrocytes with costunolide dose-dependently enhanced the percentage of annexin-V-binding cells, decreased the cell volume, depleted [GSH]i and completely inhibited G6PDH activity. The effects of costunolide on annexin-V-binding and cell volume were significantly reversed by pre-treatment of erythrocytes with the specific PKC-α inhibitor chelerythrine. The latter, however, had no effect on costunolide-induced GSH depletion. Costunolide induces eryptosis, depletes [GSH]i and inactivates G6PDH activity. Furthermore, our study reveals an inhibitory effect of chelerythrine on costunolide-induced eryptosis, indicating a relationship between costunolide and PKC-α. In addition, chelerythrine acts independently of the GSH depletion. Understanding the mechanisms of G6PDH inhibition accompanied by GSH depletion should be useful for development of anti-malarial therapeutic strategies or for synthetic lethality-based approaches to escalate oxidative stress in cancer cells for their sensitization to chemotherapy and radiotherapy.
- 650 _2
- $a apoptóza $x účinky léků $7 D017209
- 650 _2
- $a benzofenantridiny $x farmakologie $7 D053119
- 650 _2
- $a vápník $x metabolismus $7 D002118
- 650 _2
- $a inhibitory enzymů $x farmakologie $7 D004791
- 650 _2
- $a eryptóza $x účinky léků $x genetika $7 D000072817
- 650 _2
- $a erytrocyty $x účinky léků $x patologie $7 D004912
- 650 _2
- $a glukosa-6-fosfátdehydrogenasa $x antagonisté a inhibitory $x genetika $7 D005954
- 650 _2
- $a glutathion $x genetika $7 D005978
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a oxidační stres $x účinky léků $7 D018384
- 650 _2
- $a proteinkinasa C-alfa $x antagonisté a inhibitory $x genetika $7 D051571
- 650 _2
- $a reaktivní formy kyslíku $7 D017382
- 650 _2
- $a seskviterpeny $x farmakologie $7 D012717
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Koralkova, Pavla $u Department of Biology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 77515, Olomouc, Czech Republic
- 700 1_
- $a Giustarini, Daniela $u Department of Biotechnology, Chemistry and Pharmacy, Laboratory of Pharmacology and Toxicology, University of Siena, Via A Moro 2, 53100, Siena, Italy
- 700 1_
- $a Mojzikova, Renata $u Department of Biology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 77515, Olomouc, Czech Republic
- 700 1_
- $a Fehrenbacher, Birgit $u Department of Dermatology, Eberhard Karls University of Tübingen, 72074, Tübingen, Germany
- 700 1_
- $a Dreischer, Peter $u Physiologisches Institut, Abteilung für Vegetative Und Klinische Physiologie, Eberhard Karls University of Tübingen, 72074, Tübingen, Germany
- 700 1_
- $a Schaller, Martin $u Department of Dermatology, Eberhard Karls University of Tübingen, 72074, Tübingen, Germany
- 700 1_
- $a Mrowietz, Ulrich $u Psoriasis-Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Rosalind-Franklin-Str. 7, 24105, Kiel, Germany
- 700 1_
- $a Martínez-Ruiz, Antonio $u Unidad de Investigación, Hospital Santa Cristina, Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain $u Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain
- 700 1_
- $a Wieder, Thomas $u Physiologisches Institut, Abteilung für Vegetative Und Klinische Physiologie, Eberhard Karls University of Tübingen, 72074, Tübingen, Germany $u Department of Dermatology, Eberhard Karls University of Tübingen, 72074, Tübingen, Germany
- 700 1_
- $a Divoky, Vladimir $u Department of Biology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, 77515, Olomouc, Czech Republic
- 700 1_
- $a Rossi, Ranieri $u Department of Biotechnology, Chemistry and Pharmacy, Laboratory of Pharmacology and Toxicology, University of Siena, Via A Moro 2, 53100, Siena, Italy
- 700 1_
- $a Lang, Florian $u Physiologisches Institut, Abteilung für Vegetative Und Klinische Physiologie, Eberhard Karls University of Tübingen, 72074, Tübingen, Germany
- 700 1_
- $a Köberle, Martin $u Department of Dermatology and Allergology, School of Medicine, Technical University of Munich, Biedersteinerstr. 29, 80802, München, Germany
- 773 0_
- $w MED00007546 $t Apoptosis : an international journal on programmed cell death $x 1573-675X $g Roč. 25, č. 9-10 (2020), s. 674-685
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32638182 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026132849 $b ABA008
- 999 __
- $a ok $b bmc $g 1715273 $s 1147005
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 25 $c 9-10 $d 674-685 $e - $i 1573-675X $m Apoptosis $n Apoptosis $x MED00007546
- LZP __
- $a Pubmed-20211013